TRON Group Inc. (TGRP)
OTCMKTS · Delayed Price · Currency is USD
0.0350
-0.0050 (-12.50%)
Jun 10, 2026, 2:28 PM EST
TRON Group Market Cap
TRON Group has a market cap or net worth of $7.36 million as of June 10, 2026. Its market cap has decreased by -92.31% in one year.
Market Cap
7.36M
Enterprise Value
n/a
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since February 21, 2018, TRON Group's market cap has decreased from 232.00M to 7.36M, a decrease of -96.83%. That is a compound annual growth rate of -34.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 7.36M | -11.11% |
| Dec 30, 2025 | 8.28M | -35.34% |
| Dec 30, 2024 | 12.81M | -95.09% |
| Dec 27, 2021 | 261.00M | 71.71% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curative Biotechnology | 11.30M |
| Reviva Pharmaceuticals Holdings | 9.37M |
| Biomind Labs | 9.31M |
| Nymox Pharmaceutical | 9.18M |
| Brainstorm Cell Therapeutics | 8.26M |
| Synlogic | 8.07M |
| Zenith Capital | 7.99M |
| Adaptimmune Therapeutics | 7.95M |